OOIR: Observatory of International Research

Papers

(The median citation count of Seminars in Thrombosis and Hemostasis is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)

Article	Citations
	75
	47
2021 Eberhard F. Mammen Award Announcements: Part II—Young Investigator Awards	44
The Next, Next-Generation of Sequencing, Promising to Boost Research and Clinical Practice	40
Effects of Inflammation on Hemostasis in Acutely Ill Patients with Liver Disease	34
Cancer-Associated Thrombosis: Implications toward Health-Related Quality of Life	34
Hemostatic Manifestations of Invasive Fungal Infections: A Comprehensive Review of Pathophysiological Mechanisms in Sepsis-Induced Hemostatic Disturbances, with a Focus on the Neonatal Population	32
Prevention of Venous Thromboembolism in Medical Patients with Thrombocytopenia or with Platelet Dysfunction: The Last 10 Years	31
Role of Platelets in Rheumatic Chronic Autoimmune Inflammatory Diseases	31
Fright of Long-Haul Flights: Focus on Travel-Associated Thrombosis	30
Drug–Drug Interactions in the Treatment of Cancer-Associated Venous Thromboembolism with Direct Oral Anticoagulants	30
Tissue Plasminogen Activator in Central Nervous System Physiology and Pathology: From Synaptic Plasticity to Alzheimer's Disease	29
Thrombosis in Antiphospholipid Syndrome: Current Perspectives and Challenges in Laboratory Testing for Antiphospholipid Antibodies	29
Molecular Mimicry between hPF4 and SARS-CoV-2 Spike Protein: Comment	29
Application of ACR/EULAR Classification Criteria in Real Life: Thrombotic Patients Positive for Lupus Anticoagulant Only	29
Thrombotic Antiphospholipid Syndrome and Direct Oral Anticoagulants: Unmet Needs and Review of the Literature	29
Resonant Acoustic Rheometry to Measure Coagulation Kinetics in Hemophilia A and Healthy Plasma: A Novel Viscoelastic Method	28
Lupus Anticoagulant-hypoprothrombinemia Syndrome: A Review Enriched by a New Particular Patient	27
Enhanced Half-Life Recombinant Factor VIII Concentrates for Hemophilia A: Final Results from Extension Studies	26
Platelet Function Testing: Update and Future Directions	26
Testing for Lupus Anticoagulants	24
Platelet Activation and Thrombosis in COVID-19	23
Pulmonary Embolism in Patients with COVID-19: Comparison between Different Care Settings	21
Platelet Function: Acute versus Chronic Responses to Physical Exercise: A Review	21
Evolution of Clinical Trials in Anticoagulation for Sepsis: Bridging Past to Future	21

Fifty Years of Fibrinogen Structure and Function	21
Editorial Compilation—XIII	21
Autoantibodies in Autoimmune Coagulation Factor Deficiencies: A Review of Inhibitory and Clearance-Accelerating Mechanisms from Japanese Practice	20
Gene Therapy for Hemophilia B: Achievements, Open Issues, and Perspectives	20
Evolving Knowledge on Primary and Secondary Prevention of Venous Thromboembolism in Carriers of Hereditary Thrombophilia: A Narrative Review	19
How Do Laboratories Perform von Willebrand Disease Diagnostics and Classification of von Willebrand Disease Patients? Results from External Quality Data and an International Survey	19
The History of Rare Bleeding Disorders	17
Toward 50 Years of Seminars in Thrombosis and Hemostasis	17
Anti-platelet Factor 4 Antibody-Mediated Disorders: An Updated Narrative Review	17
Modulating Immune Responses: The Double-Edged Sword of Platelet CD40L	17
Investigating a Signal of Acquired Hemophilia Associated with COVID-19 Vaccination: A Systematic Case Review	16
2022 Eberhard F. Mammen Award Announcements: Part I—Most Popular Articles	16
Comprehensive Mendelian Randomization Analysis of Smoking and Its Effects on Venous Thromboembolism	16
Association between Severe Acute Respiratory Syndrome Coronavirus 2 Infection (Coronavirus Disease 2019) and Lupus Anticoagulant-Hypoprothrombinemia Syndrome: A Case Report and Literature Assessment	15
Neurocoagulation from a Mechanistic Point of View in the Central Nervous System	15
Magnetic Resonance Screening for Cerebral Venous Sinus Thrombosis during Treatment with Pegaspargase	15
Platelet Function in Patients with Disseminated Intravascular Coagulation: Potential Markers for Improving DIC Diagnosis?	14
Renal Bleeding in Patients with Impairment: A Current Perspective	14
	14
Bernard–Soulier Syndrome: A Review of Epidemiology, Molecular Pathology, Clinical Features, Laboratory Diagnosis, and Therapeutic Management	14
50 Years of Pediatric Hemostasis: Knowledge, Diagnosis, and Treatment	14
In Search of the Perfect Thrombosis and Bleeding-Associated Cancer Scale	14
Celebrating 50 Years of Seminars in Thrombosis and Hemostasis—Part III	14
From Ink Pens to Computers: A Personal Look Back at Landmark Changes during 5 Decades as a Clinical Laboratory Scientist in U.S. Hemostasis Laboratories	14
	14
Emicizumab in Type 3 von Willebrand Disease: Report of a Case with an Alloantibody and Literature Review	13
External Quality Assessment Data for Investigation of von Willebrand Disease: Focus on Relative Utility of Contemporary Functional von Willebrand Factor Assays. The United Kingdom National External Qu	13
Automation in Platelet Function Testing: Current Challenges and Future Directions	13
Laboratory Testing for the Evaluation of Phenotypic Activated Protein C Resistance	13
Mendelian Randomization Provides No Evidence for the Bidirectional Relationship between Type 2 Diabetes and Venous Thromboembolism in East Asians and African Americans	13
Use of Present-on-Admission Indicators to Improve Accuracy of Pulmonary Embolism Identification from Electronic Health Record Data	13
Seminars in Thrombosis and Hemostasis: 2024 Impact Factor, Most Highly Cited Papers, and Other Journal Metrics	13
Neutrophil Extracellular Traps: At the Interface of Thrombosis and Comorbidities	12
Colchicine as a Modulator of Platelet Function: A Systematic Review	12
Heparin-Like Anticoagulant: First Case Described in a Metastatic Biliopancreatic Cancer	12
Strength of Anticoagulation in Moderate to Severe COVID-19 Illness: In Medio Stat Virtus?	12
International Council for Standardization in Haematology Guidance for New Lot Verification of Coagulation Reagents, Calibrators, and Controls	12
The Erythrocyte–ROS Axis in Thrombosis and Hemostasis	12
A Brief History of Hemostasis and Thrombosis at the Mayo Clinic	12
	12
Clinical, Laboratory, and Molecular Aspects of Factor V Deficiency	12
Comparative Study of Venous Thromboembolic Prophylaxis Strategies for Patients with Ischemic Stroke: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials	12
Venous Thromboembolism in Children: The Rivaroxaban Experience	12
Lipopolysaccharide and Coagulation Factor XII: Biophysics of Contact Activation in Infection	12
Gene Therapy in Hemophilia A: Achievements, Challenges, and Perspectives	12
Tranexamic Acid and Its Potential Anti-Inflammatory Effect: A Systematic Review	11
Dosing Intensity of Anticoagulants for the Prevention and Treatment of Venous Thromboembolism and the Prevention of Stroke in Atrial Fibrillation: Why is There a Difference?	11
Mortality from Pulmonary Embolism in Patients with Post-Coronavirus Disease Syndrome	11
Bleeding Scoring Systems in Neonates: A Systematic Review	11
A Historical Perspective on the Reversal of Anticoagulants	11

Impact of Hematocrit on Coagulation Measured by Rotational Thromboelastometry in Healthy Subjects and Patients with Polycythemia	11
Comparison of Platelet Function Tests for Long-Term Cardiovascular Events after Percutaneous Coronary Interventions	11
Optimizing Venous Stenting: Consensus Recommendations for Enhanced Management of Lower Extremity Deep Vein Thrombosis	11
Editorial Compilation XIV	11
Pulmonary Embolism-Related Mortality in Femur Fracture Patients: A Recent Retrospective Epidemiological Analysis	11
COVID-19 Vaccine-Associated Immune Thrombosis and Thrombocytopenia (VITT): Diagnostic Discrepancies and Global Implications	11
Cancer-Associated Thrombosis and Beyond: Biomarkers, Treatments, and Cancer-Hemostasis Interactions	10
Evaluating Diagnostic Algorithms for Heparin-Induced Thrombocytopenia using Two Combined Automated Rapid Immunoassays	10
Activated Partial Thromboplastin Time and Prothrombin Time Mixing Studies: Current State of the Art	10
Thrombin Generation Assays: What are the Current Clinical Applications?	10
Precision Medicine in Rare Bleeding Disorders	10
	10
Clinical Features of Antiphospholipid Syndrome with Intracardiac Mass	10
The Applicability of Thromboelastography in Acute Ischemic Stroke: A Literature Review	10
Risk Factors for Left Ventricular Thrombus Formation in Patients with Dilated Cardiomyopathy	10
Editorial Compilation XI	10
COVID-19 and Anticoagulant Use: Did the Pandemic Push DOACs Ahead of Warfarin?	10
Do we Have the Gut to Beat Thrombosis?	10
A Perspective on How Fibrinaloid Microclots and Platelet Pathology May be Applied in Clinical Investigations	10
Past, Present, and Future Perspectives of Plasminogen Activator Inhibitor 1 (PAI-1)	10
The Pathophysiological Role of Platelet-Derived Extracellular Vesicles	9
Safety and Efficacy of Therapeutic Anticoagulation with Subcutaneous Unfractionated Heparin in Patients with Renal Failure	9
	9
Transitioning of Patients from Direct-Acting Oral Anticoagulant to Heparin: Impact on Laboratory Testing	9
Molecular Mimicry between hPF4 and SARS-CoV-2 Spike Protein: Response to Comment	9
Hematohidrosis in 15th Century Renaissance Art and a Review of Modern Literature	9
National Early Warning Score-2 for Identification of Patients with Intermediate-High-Risk Pulmonary Embolism	9
The Role of Platelets in Atherosclerosis: A Historical Review	9
Current Diagnosis of von Willebrand Disease in Italy: 3 Years Following the Release of the International Guidelines	9
Pleiotropic Effects of Heparin and its Monitoring in the Clinical Practice	9
Platelet Physiology	9
Non-factor Therapies for Hemophilia: Achievements and Perspectives	9
Hemostasis Testing in the Emergency Department: A Narrative Review	9
NETosis in Acute Thrombotic Disorders	9
	8
2022 Eberhard F. Mammen Award Announcements: Part II—Young Investigator Awards	8
Internal Quality Control in Hemostasis Assays	8
Crucial Stepping Stones in Platelet History	8
Factor Replacement Treatment for Hemophilia A: Achievements and Perspectives	8
PFA-100 System: A New Method for Assessment of Platelet Dysfunction	8
Discordant High Activated Partial Thromboplastin Time Relative to Anti-Xa Values in Hospitalized Patients is an Independent Risk Factor for Increased 30-day Mortality	8
Current Understandings on Biological Characteristics of Thrombolytics in Acute Ischemic Stroke	8
Laboratory Testing for ADAMTS13 for Thrombotic Thrombocytopenia Purpura and Beyond	8
Why Does Rivaroxaban Not Work in Severe Mitral Stenosis?	8
Emerging Use of Viscoelastography in Thrombosis and Hemostasis: A Challenge to Conventional Coagulation Tests? Part I: The Use of Thromboelastography and Thromboelastometry in the Assessment of Hemost	8
Laboratory Testing for Fibrinogen Disorders: From Routine Investigations to Research Studies	8
Increased HDL-C Values and Mortality: Revolutionizing a Historical Paradigm?	8
	7
Evolution of Antiphospholipid Syndrome	7
One Hundred Years of Congenital Fibrinogen Disorders	7
Advanced Treatment of Hemodynamically Unstable Acute Pulmonary Embolism and Clinical Follow-up	7
Application of Activators Ecarin and Factor Xa in Thrombelastography for Measurement of Anticoagulant Effect of Direct Oral Anticoagulants Using TEG 5000	7
It Is Proposed That Cardiovascular Functions are Regulated by the Status of Ecto-phosphoproteins Orchestrated by Platelets	7
Advances in the Management of Coagulopathy in Trauma: The Role of Viscoelastic Hemostatic Assays across All Phases of Trauma Care	7
Next-Generation Sequencing and Emerging Technologies*	7
New Seminars in Thrombosis and Hemostasis (STH) 2021 Impact Factor, Most Highly Cited Papers, and Other Journal Metrics	7
Clinical, Laboratory, and Molecular Aspects of Factor VII Deficiency	7
D-dimers—“Normal” Levels versus Elevated Levels Due to a Range of Conditions, Including “D-dimeritis,” Inflammation, Thromboembolism, Disseminated Intravascular Coagulation, and COVID-19	7
The More Recent History of Hemophilia Treatment	7
	7
Viscoelastic Management of Coagulopathy during the Perioperative Period of Liver Transplantation	7
Limb Ischemic Necrosis Secondary to Microvascular Thrombosis: A Brief Historical Review	6
Clinical, Laboratory Aspects and Management of Factor X Deficiency	6
Risk Factors for Major Adverse Cardiovascular Events and Major Adverse Limb Events after Venous Thromboembolism: A Large Prospective Cohort Study	6
Welcome to Seminars in Thrombosis & Hemostasis 2022	6
Deep Vein Thrombosis in Adults with HIV: A Systematic Review and Meta-analysis of Prevalence and Risk Factors	6
Against Therapeutic Anticoagulation in Critically Ill COVID-19 Patients	6
Nebulized Heparin in 2025: at the Interface between Promising Benefits and the Need for Further Research	6
Antiplatelet Therapy in Coronary Artery Disease: Now and Then	6
Factor VIII and Factor IX Activity Measurements for Hemophilia Diagnosis and Related Treatments	6
Secondary Anticoagulation Use in Patients < 21 Years Old following Primary Anticoagulant Treatment for Provoked Venous Thromboembolism: Findings from the Kids-DOTT Trial	6
Risk Factors for Antiphospholipid Antibodies and Antiphospholipid Syndrome	6
Cellular Components Contributing to the Development of Venous Thrombosis in Patients with Pancreatic Cancer	6
Hereditary Angioedema: The Clinical Picture of Excessive Contact Activation	6
Comparison of Thrombophilia Assay Results for the International Society on Thrombosis and Haemostasis Scientific and Standardization Committee Plasma Standard from Different External Quality Assessmen	6
Monitoring Hemostatic Function during Cardiac Surgery with Point-of-Care Viscoelastic Assays: A Narrative Review	6
Platelet Function in Acute Kidney Injury: A Systematic Review and a Cohort Study	6
Platelets in Vascular Calcification: A Comprehensive Review of Platelet-Derived Extracellular Vesicles, Protein Interactions, Platelet Function Indices, and their Impact on Cellular Crosstalk	5
Thrombosis Risk Assessment in Myeloproliferative Neoplasm—Is There a Role for Viscoelastic Testing?	5
Anticoagulation with Intravenous Direct Thrombin Inhibitors in Pediatric Extracorporeal Membrane Oxygenation: A Systematic Review of the Literature	5

The Benefits of Heparin Use in COVID-19: Pleiotropic Antiviral Activity beyond Anticoagulant and Anti-Inflammatory Properties	5
Platelets in Neonatal Sepsis: Beyond Clotting, From Silent Players to Immune Orchestrators	5
Plasma Kallikrein as a Forgotten Clotting Factor	5
Red Blood Cells and Tranexamic Acid in the Inhibition of Fibrinolysis	5
Human Genetic Variation in F3 and Its Impact on Tissue Factor–Dependent Disease	5
Dosing, Monitoring, Blood Product Utilization, and Thromboembolic Complications of Four-Factor Prothrombin Complex Concentrate as Part of an Institutional Protocol in Pediatric Cardiac Surgery: A Retr	5
Role of Circulating Microparticles in Type 2 Diabetes Mellitus: Implications for Pathological Clotting	5
A Novel Variant on the Thrombospondin Type-1 Repeat 2 Domain of ADAMTS13 in a Parturient with Suspected Hereditary Thrombotic Thrombocytopenic Purpura and Unusually High ADAMTS13 Activity	5
Nonsevere Hemophilia: The Need for a Renewed Focus and Improved Outcomes	5
Unlocking the Potential of MicroRNA Expression: Biomarkers for Platelet Reactivity and Coronary Artery Disease	5
What Role Does Microthrombosis Play in Long COVID?	5
Has “D-Dimeritis” Worsened during the Coronavirus Disease 2019 Pandemic?	5
Antiphospholipid Antibodies in Pregnancy: Maternal and Neonatal Implications	5
Antiphospholipid Syndrome in Patients with Venous Thromboembolism	5
Laboratory Evaluation of Antithrombin, Protein C, and Protein S	5
2023 Eberhard F. Mammen Award Announcements: Part II–Young Investigator Awards	5
Congenital Bleeding Disorders and COVID-19—A Systematic Literature Review	5
Impact of Viral Infections on the Hemostatic System	5
Variable Performance of Lupus Anticoagulant Testing: The Australasian/Asia-Pacific Experience	5
	5
The Pitfalls of Global Hemostasis Assays in Myeloproliferative Neoplasms and Future Challenges	5
Reviewing the Rich History of Fibrin Clot Research with a Focus on Clinical Relevance	5
Detecting Oxygenator Thrombosis in ECMO: A Review of Current Techniques and an Exploration of Future Directions	5
Coronary Thrombosis with Distal Embolization in a Young Patient after Orthopaedic Surgery: An Informative Case Report	4
Causal Associations Between Cardiovascular Risk Factors and Venous Thromboembolism	4
Correlation between Phenotype and Coagulation Factor Activity Level in Rare Bleeding Disorders: A Systematic Review	4
	4
Relative Hypercoagulopathy of the SARS-CoV-2 Beta and Delta Variants when Compared to the Less Severe Omicron Variants Is Related to TEG Parameters, the Extent of Fibrin Amyloid Microclots, and the Se	4
Causal Relationships of Circulating Inflammatory Proteins and Portal Vein Thrombosis: A Mendelian Randomization Study	4
Parathyroid Adenoma in a Young Girl with Type 3 von Willebrand Disease: Comment on “Cancers in Patients with von Willebrand Disease”	4
New Horizons in Fetal and Neonatal Alloimmune Thrombocytopenia	4
Viscoelastic Testing in the Clinical Management of Subarachnoid Hemorrhage and Intracerebral Hemorrhage	4
A Critical Reappraisal of the Bleeding Time	4
Thrombosis in Pregnant Women with Hematological Malignancies: A Case-Based Review	4
Diagnosis and Treatment of Autoimmune Acquired Coagulation Factor Deficiencies: An Evidence-Based Review of Japanese Practice	4
Comparative Analysis of Four Risk Stratification Models to Identify Patients with Acute Pulmonary Embolism at Risk of Short-term Mortality	4
Risk Factors of Catheter-Related Thrombosis in Elderly Patients with Lung Cancer Based on Thromboelastography: A Retrospective, Case-Control Study	4
Heparins May Not Be the Optimal Anticoagulants for Sepsis and Sepsis-Associated Disseminated Intravascular Coagulation	4
Antiphospholipid Antibodies in Mental Disorders	4
Platelets: Physiology and Biochemistry	4
Clinical Studies with Anticoagulants that Have Changed Clinical Practice	4
Measuring Quality of Life after Venous Thromboembolism: Who, When, and How?	4
Platelet Contributions to the (Pre)metastatic Tumor Microenvironment	4
Mutations Accounting for Congenital Fibrinogen Disorders: An Update	4
Pearls and Pitfalls in the Measurement of Direct Oral Anticoagulants	4
Vascular Pathogenesis in Acute and Long COVID: Current Insights and Therapeutic Outlook	4
Epidemiology and Predisposing Factors of Post-COVID Venous Thrombosis: A Concise Review	4
Classification Criteria for the Antiphospholipid Syndrome: Not the Same as Diagnostic Criteria for Antiphospholipid Syndrome	4
Venous Thromboembolism after Hospital Discharge: Temporal Trends in Baseline Characteristics, Prevention, Treatment, and 90-day Outcomes	4
Hemostasis, Thrombosis, and Vascular Biology in Psychiatric Disorders	4
Laser-Induced Blood Coagulation for Surgical Application: A Scoping Review	4
Targeting the Contact Pathway of Coagulation for the Prevention and Management of Medical Device-Associated Thrombosis	4
Red Blood Cells are Critical for Hemostasis and Thrombosis	4
Is Vitamin D Deficiency Prothrombotic? A Systematic Review	4
Role of Viscoelastic and Conventional Coagulation Tests for Management of Blood Product Replacement in the Bleeding Patient	4
Editorial Compilation—XV	4
The ABO Blood System and Associated Implications for Hemostasis and Thrombosis	4
Editorial Compilation XII	4
Viscoelastic Hemostatic Assays in Sepsis: From Pathophysiology to Potential Clinical Implications	4
Assessment of Hemostatic Profile in Neonates with Intrauterine Growth Restriction: A Systematic Review of Literature	4
Pathogen Reduction Technologies and Their Impact on Metabolic and Functional Properties of Treated Platelet Concentrates: A Systematic Review	4
Neutrophil-Mediated Effects on Hemostasis and Thrombosis: Unraveling Their Complex Interaction in Thrombotic Events	4
Solid Phase Assays for Antiphospholipid Antibodies	3
Tranexamic Acid: An Evergreen Hemostatic Agent	3
“True” Antiphospholipid Syndrome in COVID-19: Contribution of the Follow-up of Antiphospholipid Autoantibodies	3
	3
Risk of Venous Thromboembolism by Cancer Type: A Network Meta-Analysis	3
From the Discovery of ADAMTS13 to Current Understanding of Its Role in Health and Disease	3
Prophylaxis of Venous Thromboembolism in Children: A Systematic Review	3
Sudden Cardiac Arrest and Death in Sports: An Updated Overview of Epidemiology, Etiologies, and Prevention Strategies, with Emphasis on Inherited Cardiomyopathies	3
Prediction of Recurrent Venous Thromboembolism and Arterial Cardiovascular Events after Discontinuation of Anticoagulation: The R-VTE-predict and MACE-predict Risk Scores	3
The History of Extracorporeal Membrane Oxygenation and the Development of Extracorporeal Membrane Oxygenation Anticoagulation	3
Changes in Coagulation in Cancer Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Treatment (HIPEC)—A Systematic Review	3
Venous Thrombosis in Airborne Viral Infections: Is Coronavirus Disease 2019 now Any Different from Influenza?	3
Patient Perspective on Disease Burden and Gene Therapy for Hemophilia A and B: The “Haemvolution for Patients” Italian Survey	3
Arterial Thrombotic Events in Hospitalized COVID-19 Patients: A Short Review and Meta-Analysis	3
Evaluating Performance of Contemporary and Historical von Willebrand Factor (VWF) Assays in the Laboratory Identification of von Willebrand Disease (VWD): The Australasian Experience	3
Optimizing and Extending the Risk-Adapted Management of Acute Pulmonary Embolism beyond the Acute Phase: Progress in Pulmonary Embolism Research	3
The Evolution of Hemophilia Pharmacological Treatments and Therapeutic Targets at the Turn of the Third Millennium	3
Evolution of Hemostasis Testing: A Personal Reflection Covering over 40 Years of History*	3
Post COVID-19 Large Vessel Vasculopathy in a Previously Healthy Young Male	3
Recommendations on the use of COVID-19 Convalescent Plasma to Treat Immunocompromised Patients	3
Inherited or Immunological Thrombocytopenia: The Complex Nature of Platelet Disorders in 22q11.2 Deletion Syndrome	3
Are Antiphospholipid Antibodies a Surrogate Risk Factor for Thrombosis in Sepsis?	3
A Review of Autoimmune Acquired von Willebrand Factor Deficiency in Japan	3
Systemic Antiangiogenic Therapies for Bleeding in Hereditary Hemorrhagic Telangiectasia: A Practical, Evidence-Based Guide for Clinicians	3
Stability of Hemostasis Parameters in Whole Blood, Plasma, and Frozen Plasma: Literature Review and Recommendations of the SFTH (French Society of Thrombosis and Haemostasis)	3
Measurement Uncertainty in the Hemostasis Laboratory	3
Sex-Related Differences in Patient Characteristics, Risk Factors, and Symptomatology in Older Adults with Pulmonary Embolism: Findings from the SERIOUS-PE Study	3
	3
Hemostatic and Inflammatory Biomarkers are Associated with Functional Limitations after Venous Thromboembolism: A Prospective Cohort Study	3
	3
Hereditary Angioedema and Venous Thromboembolism: Where There's Smoke, There's Fire	3
Corrigendum: Lupus Anticoagulant-hypoprothrombinemia Syndrome: A Review Enriched by a New Particular Patient	3
From Field Study to Clinical Practice, a Personal Historical Experience Using the PFA-100 Analyzer for Platelet Function Testing	3